WHO ICTRP trial
a study to compare difference between effect of addition of magnesium sulphate…
CTRI/2021/12/038939 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/12/038939 |
|---|---|
| Public title | a study to compare difference between effect of addition of magnesium sulphate to ropivacaine in epidural anaesthesia |
| Scientific title | A STUDY TO COMPARE EPIDURAL MAGNESIUM SULPHATE AS ADD ON TO ROPIVACAINE WITH ROPIVACAINE ALONE FOR LOWER LIMB SURGERIES |
| Primary sponsor | DR SEEMA JINDAL |
| Secondary sponsors | DR SARVJEET KAUR |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: O- Medical and Surgical Health Condition 2: M21- Other acquired deformities of limbs |
| Interventions | Control Intervention1: epidural magnesium sulphate: two groups of patient will be made one group will receive 20ml of drug containing 0.75% ropivacaine 19ml(142.5) and 1ml of magnesium sulphate 50 mg epidurally and 2nd group will containe… |
| Registration date | Dec 27, 2021 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: